Design Therapeutics Inc (DSGN) stock news · $214.0M cap
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
This DSGN news page leads with what Design Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for DSGN yet. We will not pad this page with generic market recap.
Latest reported DSGN revenue for 2025-12-31 was $0. Net income was -$69.8M. DSGN currently screens at market cap $214.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the DSGN stock page; for the tape open the quote page.
DSGN stock news FAQ
What is DSGN's latest net income?
Latest cached Design Therapeutics Inc (DSGN) net income was -$69.8M. Statements: https://lician.com/financials/dsgn
What is DSGN's market cap?
Design Therapeutics Inc (DSGN) market cap is $214.0M on the latest cached fundamentals snapshot.
What kind of company is DSGN?
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Where is DSGN stock news listed?
Cached stock news for Design Therapeutics Inc (DSGN) is listed at https://lician.com/news/dsgn. Filings: https://lician.com/sec/dsgn
Not investment advice.